CA3079373A1 - Cerebral hypofunction inhibitor or cerebral hypofunction prophylactic agent containing carotenoid composition - Google Patents

Cerebral hypofunction inhibitor or cerebral hypofunction prophylactic agent containing carotenoid composition Download PDF

Info

Publication number
CA3079373A1
CA3079373A1 CA3079373A CA3079373A CA3079373A1 CA 3079373 A1 CA3079373 A1 CA 3079373A1 CA 3079373 A CA3079373 A CA 3079373A CA 3079373 A CA3079373 A CA 3079373A CA 3079373 A1 CA3079373 A1 CA 3079373A1
Authority
CA
Canada
Prior art keywords
mass
carotenoid
composition
brain
hypofunction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA3079373A
Other languages
English (en)
French (fr)
Inventor
Takashi Ishibashi
Masahiro Hayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eneos Corp
Original Assignee
JXTG Nippon Oil and Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JXTG Nippon Oil and Energy Corp filed Critical JXTG Nippon Oil and Energy Corp
Publication of CA3079373A1 publication Critical patent/CA3079373A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/045—Organic compounds containing nitrogen as heteroatom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Botany (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA3079373A 2017-10-27 2018-05-24 Cerebral hypofunction inhibitor or cerebral hypofunction prophylactic agent containing carotenoid composition Abandoned CA3079373A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2017208154A JP2019077664A (ja) 2017-10-27 2017-10-27 カロテノイド組成物を含有する脳機能低下抑制剤または脳機能低下予防剤
JP2017-208154 2017-10-27
PCT/JP2018/020051 WO2019082430A1 (ja) 2017-10-27 2018-05-24 カロテノイド組成物を含有する脳機能低下抑制剤または脳機能低下予防剤

Publications (1)

Publication Number Publication Date
CA3079373A1 true CA3079373A1 (en) 2019-05-02

Family

ID=66247237

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3079373A Abandoned CA3079373A1 (en) 2017-10-27 2018-05-24 Cerebral hypofunction inhibitor or cerebral hypofunction prophylactic agent containing carotenoid composition

Country Status (4)

Country Link
US (1) US20210186895A1 (cg-RX-API-DMAC7.html)
JP (1) JP2019077664A (cg-RX-API-DMAC7.html)
CA (1) CA3079373A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019082430A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220054432A1 (en) * 2018-11-05 2022-02-24 Eneos Corporation Composition for increasing retention of carotenoid in blood
JPWO2021045138A1 (cg-RX-API-DMAC7.html) * 2019-09-04 2021-03-11

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001002569A (ja) * 1999-06-18 2001-01-09 Itano Refrigerated Food Co Ltd 記憶力改善組成物
JP2007126455A (ja) * 2005-10-07 2007-05-24 Fuji Chem Ind Co Ltd 脳機能障害の改善剤
JP2012025712A (ja) * 2010-07-27 2012-02-09 Jx Nippon Oil & Energy Corp 抗不安組成物
JP6218624B2 (ja) * 2014-01-30 2017-10-25 Ｊｘｔｇエネルギー株式会社 虚血性疾患を予防するための薬剤

Also Published As

Publication number Publication date
US20210186895A1 (en) 2021-06-24
WO2019082430A1 (ja) 2019-05-02
JP2019077664A (ja) 2019-05-23

Similar Documents

Publication Publication Date Title
US6932990B2 (en) Carbohydrate absorption inhibitor and method for manufacturing the same
EP1252892A1 (en) Composition for reducing mental fatigue, composition for maintaining and enhancing concentration, and composition for maintaining and enhancing mental vigor
KR20080030633A (ko) 스트레스의 치료 또는 처치방법
KR102038810B1 (ko) 성장 호르몬 분비 촉진제
US20140050805A1 (en) Composition, glucose metabolism-improving agent, and method for improving glucose metabolism
KR20140082666A (ko) 수면의 질 개선제
US20210186895A1 (en) Cerebral hypofunction inhibitor or cerebral hypofunction prophylactic agent containing carotenoid composition
JPH10276721A (ja) アスタキサンチン含有飲食物
WO2004112510A1 (ja) 運動生理機能向上剤
KR100456281B1 (ko) 방광기능개선제 또는 배뇨장애치료제, 및 방광기능개선용또는 배뇨장애치료용 음식물
WO2002094253A1 (en) Agents for relieving eye controlling function error
US10695369B2 (en) Cognitive function-remedying agent
JP2018150240A (ja) 骨形成促進剤及びそれを用いた飲食品組成物
KR102722498B1 (ko) 인지 기능 개선용 조성물 및 불안양 증상 개선용 조성물, 및 뇌 위축 억제용 조성물
US11504352B2 (en) Composition for ameliorating circulatory system diseases, comprising tea extract with modified ingredients content
WO2006132223A1 (ja) 抗高血圧組成物
KR20160007709A (ko) 천연 당 시럽 및 그 제조 방법
JP2003286164A (ja) アセチルコリンエステラーゼ阻害剤
JP4334834B2 (ja) 膀胱機能改善剤又は排尿障害治療剤
KR100965121B1 (ko) 진저롤을 함유하는 알코올성 태아기형 예방 및 치료용조성물
KR101627546B1 (ko) 리파아제 저해 활성을 갖는 프로토카테큐산 유도체 및 이의 용도
JP7530200B2 (ja) 皮膚における赤み改善剤
Roberts Diagnosis and Treatment of Nonsuppurative Sinusitis
KR20190125804A (ko) 겐티아나 루테아 추출물 또는 이로부터 분리된 화합물을 유효성분으로 포함하는 인지 기능 장애 예방 또는 치료용 조성물
KR20250145285A (ko) 릴메니딘을 포함하는 정서장애의 예방, 개선 또는 치료용 조성물

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20231124